Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What upper market value could the Prosthetic Heart Valve Devices And Equipment Market reach by 2030 starting from 2026 levels?
The prosthetic heart valve devices and equipment market size has seen strong growth in recent years. It is anticipated to expand from $6.73 billion in 2025 to $7.17 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. This historical growth can be attributed to factors such as the increasing prevalence of valvular heart diseases, a rising aging population, the expansion of cardiac surgery programs, the growing adoption of valve replacement procedures, and improvements in cardiac imaging technologies.
The prosthetic heart valve devices and equipment market is anticipated to experience substantial expansion in the coming years. Its size is projected to reach $10.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This projected growth is driven by several factors, including an increasing inclination towards minimally invasive cardiac procedures, a growing need for more durable valve implants, the broadening scope of transcatheter valve applications, rising investments in treating structural heart conditions, and advancements in biological valve materials. Key trends anticipated during this period encompass the wider embrace of transcatheter heart valve procedures, a heightened demand for tissue-based heart valves, greater utilization of minimally invasive systems for valve repair, the expansion of advanced valve durability technologies, and an intensified focus on tailored valve solutions for individual patients.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2416&type=smp
Which Drivers Are Influencing Long-Term Growth In The Prosthetic Heart Valve Devices And Equipment Market?
The increasing occurrence of valvular heart disease has spurred the demand for transcatheter aortic valve replacement (TAVR) procedures, consequently boosting the prosthetic heart valve devices and equipment market. TAVR, a minimally invasive surgical intervention, addresses aortic stenosis – a valvular heart condition where the aortic valve hardens, obstructing proper blood flow. This procedure replaces the impaired aortic valve with a transcatheter valve. Illustratively, data from the US-based government agency, the Centers for Disease Control and Prevention, showed that in May 2023, heart disease claimed the lives of over 695,000 people in the US, representing one out of every five deaths. With the growing incidence of valvular heart diseases, an uptick in TAVR procedures is anticipated, simultaneously escalating the need for transcatheter valves, thereby propelling the market’s expansion.
How Is The Prosthetic Heart Valve Devices And Equipment Market Divided Into Segments?
The prosthetic heart valve devices and equipment market covered in this report is segmented –
1) By Product Type: Repair Products, Mitral Valve Repair Devices, Tricuspid Valve Repair Devices
2) By Valve Type: Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve
3) By Technology: Biological Valve, Decellularized Valve
4) By Application: Hospitals, Ambulatory Surgery Centres
Subsegments:
1) By Repair Products: Transcatheter Mitral Valve Repair (TMVR) Devices, Transcatheter Tricuspid Valve Repair (TTVR) Devices
2) By Mitral Valve Repair Devices: Mitral Valve Repair Systems (MitraClip), Mitral Valve Annuloplasty Devices, Edge-to-Edge Repair Devices
3) By Tricuspid Valve Repair Devices: Tricuspid Valve Annuloplasty Devices, Tricuspid Valve Repair Systems
Which Trends Are Influencing The Development Of The Prosthetic Heart Valve Devices And Equipment Market?
Leading companies in the prosthetic heart valve devices and equipment market are focused on developing tricuspid valve replacement systems. This development aims to meet the increasing demand for effective therapies for tricuspid valve disease, enhance patient outcomes, and reduce the complications linked with traditional heart valve surgeries. Tricuspid valve replacement systems are medical devices specifically designed to replace the heart’s tricuspid valve, which regulates blood flow between the right atrium and right ventricle. For example, in October 2023, Edwards Lifesciences, a US-based technology company, obtained CE Mark approval for its EVOQUE system, establishing it as the world’s first transcatheter valve replacement therapy approved for treating tricuspid regurgitation (TR). The EVOQUE valve is characterized by a nitinol self-expanding frame and tissue leaflets derived from bovine pericardial tissue. It is engineered for delivery through a low-profile transfemoral 28-French system and will be made available in three sizes.
Which Leading Companies Dominate The Prosthetic Heart Valve Devices And Equipment Market Share?
Major companies operating in the prosthetic heart valve devices and equipment market are Boston Scientific Corporation, Edwards Lifesciences, Medtronic plc, LivaNova plc, Abbott Laboratories, Jenavalve Technology Inc., Lepu Medical Technology, Cryolife Inc., Neovasc Inc., Braile Biomedica, Colibri Heart Valve, TTK Healthcare Ltd., Medical Technology Est., Micro Interventional Devices Inc., Well Health Technologies, On-X Life Technologies Inc., Meril Life Sciences Pvt. Ltd., Sorin Group, Commonwealth Edison Company, Cardiac Dimensions Inc., CardioSolutions Inc., Leman Cardiovascular, MitralSolutions Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Xeltis AG, Transcatheter Technologies GmbH, Venus Medtech (Hangzhou) Inc., MValve Technologies Ltd., MVRx Inc., NaviGate Cardiac Structures Inc., Pulmonx Corporation, Tendyne Holdings Inc., ValveXchange Inc., Vascutek Ltd., XpandOrtho Inc., Zhejiang A&F Medical Co. Ltd.
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Prosthetic Heart Valve Devices And Equipment Market?
North America was the largest region in global prosthetic heart valve devices and equipment market in 2025. Western Europe was the second-largest region in prosthetic heart valve devices and equipment market. The regions covered in the prosthetic heart valve devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Prosthetic Heart Valve Devices And Equipment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2416&type=smp
Browse Through More Reports Similar to the Global Prosthetic Heart Valve Devices And Equipment Market 2026, By The Business Research Company
Cardiac Prosthetic Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report
Cardiovascular Surgery Devices And Equipment Global Market Report 2026
Heart Pump Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company